FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemiaAugust 17, 2022Transfusion MedicinePediatricsAnemia
Phase 3 data: Zanubrutinib bests standard CLL treatmentAugust 16, 2022CLLMantle Cell LymphomaB Cell Lymphoma
Saddled with med school debt, yet left out of loan forgiveness plansAugust 11, 2022Business of Medicine
Long COVID doubles risk of some serious outcomes in children, teensAugust 5, 2022Long COVIDCOVID-19 UpdatesPediatricsThrombosis
Many die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
